The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity Disorder

2011/05/09 by Natalia del Campo, Samuel R. Chamberlain, Barbara J. Sahakian +1 · 35 citations
Medicine · Neuroscience · #Attention Deficit Hyperactivity Disorder #Functional Brain Connectivity Studies #Neurotransmitter Receptor Influence on Behavior

paper · doi:10.1016/j.biopsych.2011.02.036

Citations

• Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
• Depressed Dopamine Activity in Caudate and Preliminary Evidence of Limbic Involvement in Adults With Attention-Deficit/Hyperactivity Disorder

Cited by

• When Pathways Converge: Iron, Lipid Peroxidation, and α‐Synuclein in Ferroptosis‐Driven Dopaminergic Neurodegeneration
• Neuroinflammation as a risk factor for attention deficit hyperactivity disorder
• An fMRI examination of the role of the Locus Coeruleus in state regulation in ADHD
• Validating molecular target-enriched fMRI for disentangling drug effects on dopamine
• Tryptophan modulation in individuals with attention deficit hyperactivity disorder: a systematic review
• Noradrenaline tracks emotional modulation of attention in human amygdala
• Disrupted circadian rhythms and opioid‐mediated adverse effects: Bidirectional relationship and putative mechanisms
• Mouse model of atypical DAT deficiency syndrome uncovers dopamine dysfunction associated with parkinsonism and ADHD
• Modelling ADHD: A review of ADHD theories through their predictions for computational models of decision-making and reinforcement learning
• The effects of stimulant and non-stimulant medications on the autonomic nervous system (ANS) functioning in people with ADHD: A systematic review and meta-analysis
• Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. [europepmc]
• Prenatal immune activation interacts with genetic Nurr1 deficiency in the development of attentional impairments. [europepmc]
• Developmental changes in human dopamine neurotransmission: cortical receptors and terminators. [europepmc]
• Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons. [europepmc]
• Prenatal methylmercury, postnatal lead exposure, and evidence of attention deficit/hyperactivity disorder among Inuit children in Arctic Québec. [europepmc]
• Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys. [europepmc]
• Sex differences in impulsive action and impulsive choice. [europepmc]
• New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity. [europepmc]
• Prenatal phthalate exposures and neurobehavioral development scores in boys and girls at 6-10 years of age. [europepmc]
• Brainstem abnormalities in attention deficit hyperactivity disorder support high accuracy individual diagnostic classification. [europepmc]
• Aerobic exercise and attention deficit hyperactivity disorder: brain research. [europepmc]
• Resting-State Functional Connectivity of the Locus Coeruleus in Humans: In Comparison with the Ventral Tegmental Area/Substantia Nigra Pars Compacta and the Effects of Age. [europepmc]
• Atomoxetine: A Review of Its Pharmacokinetics and Pharmacogenomics Relative to Drug Disposition. [europepmc]
• Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease. [europepmc]
• Latent traits of impulsivity and compulsivity: toward dimensional psychiatry. [europepmc]
• Sleep disorders in patients with ADHD: impact and management challenges. [europepmc]
• A Model for Basic Emotions Using Observations of Behavior in Drosophila . [europepmc]
• Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. [europepmc]
• Dysfunction of the corticostriatal pathway in autism spectrum disorders. [europepmc]
• Role of Oxidative Stress and Neuroinflammation in Attention-Deficit/Hyperactivity Disorder. [europepmc]
• Differential attentional control mechanisms by two distinct noradrenergic coeruleo-frontal cortical pathways. [europepmc]
• Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications. [europepmc]
• Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction. [europepmc]
• G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. [europepmc]
• An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder. [europepmc]